Interventional Cardiology and Peripheral Vascular Devices Market: Including Top Companies Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc.

Interventional Cardiology and Peripheral Vascular Devices Market is estimated to garner $25,349 million by 2022, registering a CAGR of 9.7% during the period 2016-2022.

Angioplasty stent systems are estimated to generate the highest revenue among all segments throughout the forecast period, owing to technological advancements and development of bioabsorbable stents. North America held the leading position in the global market in 2015, and is expected to maintain its lead in the future. This is attributed to the increase in incidence of heart failures, changes in lifestyle, and high adoption of interventional cardiology and peripheral vascular devices in the region.

Growth in geriatric population,increase in prevalence of chronic diseases, changes in lifestyle of the people, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, stringent approval process for interventional cardiology and peripheral vascular devices is a major factor that hampers the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1072?utm_source=sy-Openpr

Key players have adopted product development as their key strategy to cater to the changing needs of the industry.

Major players operating in this market include
• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• C. R. Bard Inc.
• Cardinal Health Inc.
• Cook Medical Inc.
• Medtronic plc
• St. Jude Medical Inc.
• Terumo Corporation
• The Spectranetics Corporation

As of 2015, Medtronic dominated the overall renal denervation market, followed by Abbott Laboratories and Boston Scientific Corporation.

Plaque modification devices are projected to be thefastest growing segment, with a CAGR of 13.7% from 2016 to 2022, as these devices provide an efficient alternative when ballooning of arteries fail. In addition, plaque removal is also important before a stent implant as this helps in prevention of restenosis in the arteries. Apart from this, increase in incidences of plaque buildup in coronary as well as peripheral arteries and minimally invasive nature of the procedure will also drive the market.

Bioabsorbable stents system is expected to register a very high CAGR of 46.0% during the forecast period as this system is fully absorbed into the body and eliminates chances of restenosis. In addition, bioabsorbable stents improve endothelial function, avoid the loss of blood, and restore normal vasomotion. This is not possible when bare metal stents are used. Therefore, bioabsorbable stents would grow with a very high growth rate.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/1072?utm_source=sy-Openpr

Key findings of the Interventional Cardiology and Peripheral Vascular Devices Market:
• On the basis of product type, angioplasty stents segment accounted for more than half of the total market in 2015.
• Plaque modification devices are expected to grow at high rate (with a CAGR of 13.7%) as use of these devices before stent implant decreases the chances of restenosis.
• North America accounted for more than one-third of the total market in 2015, and it is projected to lead the overall market in the forecast period.
• Asia-Pacific is expected to be the fastest growing region (with a CAGR of 10.4%) throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of cardiac disorders in this region.

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/interventional-cardiology-and-peripheral-vascular-devices-market.html?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.